|
|
||||||||
Laboratory of Microbial Immunity, National Institute of Allergy and Infectious Diseases; Viral Oncology Program, National Cancer Institute; and Transplantation Biology Section, Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
Abstract
Five spontaneously derived BALB/c tumors and one 1-ethyl-1-nitrosourea induced BALB/c tumor (BALENLM 17), have been established in culture and characterized according to their surface markers. K46, X16C, L10A, and BALENLM 17 are IgM+, IgG-, IgA-, Ig+ (staining with polyvalent anti-Ig), Ia+, Fc receptor+ and complement receptor-. A20 is IgM-, IgG-, IgA-, Ig+, Ia+, Fc receptor+, and complement receptor-. M12 is IgM-, IgG-, IgA-, Ig±, Ia-, Fc receptor+ and complement receptor-. All these lines are Thy 1.2 antigen negative, do not phagocytize latex particles, and grow as stationary suspension cultures. Therefore these six BALB/c lymphoid lines are presumably of B cell origin at various stages of differentiation. All these lines except X16C are tumorigenic in mice within a short period of time and have relatively short generation times in the range of 18 to 26 hr. Karyotype studies show that L10A, K46, X16C, and BALENLM 17 are hyperdiploid to hypotetraploid. A20 and M12 have near diploid chromosome numbers.
This article has been cited by other articles:
![]() |
R. E. McMillan and M. L. Sikes Differential Activation of Dual Promoters Alters D{beta}2 Germline Transcription during Thymocyte Development J. Immunol., March 1, 2008; 180(5): 3218 - 3228. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Persson, A. M. Agnarson, H. Lambert, N. Hitziger, H. Yagita, B. J. Chambers, A. Barragan, and A. Grandien Death Receptor Ligation or Exposure to Perforin Trigger Rapid Egress of the Intracellular Parasite Toxoplasma gondii J. Immunol., December 15, 2007; 179(12): 8357 - 8365. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Rinderknecht, M. P. Belmares, T. L. W. Catanzarite, A. J. Bankovich, T. H. Holmes, K. C. Garcia, N. K. Nanda, R. Busch, S. Kovats, and E. D. Mellins Posttranslational Regulation of I-Ed by Affinity for CLIP J. Immunol., November 1, 2007; 179(9): 5907 - 5915. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, M. Veselits, S. O'Neill, P. Hou, A. L. Reddi, I. Berlin, M. Ikeda, P. D. Nash, R. Longnecker, H. Band, et al. Ubiquitinylation of Igbeta Dictates the Endocytic Fate of the B Cell Antigen Receptor J. Immunol., October 1, 2007; 179(7): 4435 - 4443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Rowland, M. M. Tremblay, J. M. Ellison, L. L. Stunz, G. A. Bishop, and B. S. Hostager A Novel Mechanism for TNFR-Associated Factor 6-Dependent CD40 Signaling J. Immunol., October 1, 2007; 179(7): 4645 - 4653. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Fredriksen and B. Bogen Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences Blood, September 15, 2007; 110(6): 1797 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Biragyn, R. Schiavo, P. Olkhanud, K. Sumitomo, A. King, M. McCain, F. E. Indig, G. Almanzar, and D. Baatar Tumor-Associated Embryonic Antigen-Expressing Vaccines that Target CCR6 Elicit Potent CD8+ T Cell-Mediated Protective and Therapeutic Antitumor Immunity J. Immunol., July 15, 2007; 179(2): 1381 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Elpek, C. Lacelle, N. P. Singh, E. S. Yolcu, and H. Shirwan CD4+CD25+ T Regulatory Cells Dominate Multiple Immune Evasion Mechanisms in Early but Not Late Phases of Tumor Development in a B Cell Lymphoma Model J. Immunol., June 1, 2007; 178(11): 6840 - 6848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Casals, M. Barrachina, M. Serra, J. Lloberas, and A. Celada Lipopolysaccharide Up-Regulates MHC Class II Expression on Dendritic Cells through an AP-1 Enhancer without Affecting the Levels of CIITA J. Immunol., May 15, 2007; 178(10): 6307 - 6315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mertz, R. Kobayashi, and J. P. Dudley ALY Is a Common Coactivator of RUNX1 and c-Myb on the Type B Leukemogenic Virus Enhancer J. Virol., April 1, 2007; 81(7): 3503 - 3513. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Schjetne, A. B. Fredriksen, and B. Bogen Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors J. Immunol., April 1, 2007; 178(7): 4169 - 4176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sato, T. Adachi, and T. Tsubata Augmentation of Signaling through BCR Containing IgE but not That Containing IgA Due to Lack of CD22-Mediated Signal Regulation J. Immunol., March 1, 2007; 178(5): 2901 - 2907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Kharas, I. Yusuf, V. M. Scarfone, V. W. Yang, J. A. Segre, C. S. Huettner, and D. A. Fruman KLF4 suppresses transformation of pre-B cells by ABL oncogenes Blood, January 15, 2007; 109(2): 747 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Erlach, V. Bohm, C. K. Seckert, M. J. Reddehase, and J. Podlech Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection. J. Virol., May 1, 2006; 80(10): 4801 - 4819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Moldovan, L. Sabbagh, G. Breton, R.-P. Sekaly, and M. F. Krummel Triggering of T Cell Activation via CD4 Dimers J. Immunol., May 1, 2006; 176(9): 5438 - 5445. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. MA, S. I. GUNDERSON, and C. PHILLIPS Non-snRNP U1A levels decrease during mammalian B-cell differentiation and release the IgM secretory poly(A) site from repression RNA, January 1, 2006; 12(1): 122 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Moore and G. A. Bishop Differential Regulation of CD40-Mediated TNF Receptor-Associated Factor Degradation in B Lymphocytes J. Immunol., September 15, 2005; 175(6): 3780 - 3789. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Rubio, T. I. Saito, K. Kattleman, G. Zhao, J. Buchli, and M. Sykes Mechanisms of the Antitumor Responses and Host-versus-Graft Reactions Induced by Recipient Leukocyte Infusions in Mixed Chimeras Prepared with Nonmyeloablative Conditioning: A Critical Role for Recipient CD4+ T Cells and Recipient Leukocyte Infusion-Derived IFN-{gamma}-Producing CD8+ T Cells J. Immunol., July 15, 2005; 175(2): 665 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Song and R. Levy Therapeutic Vaccination against Murine Lymphoma by Intratumoral Injection of Naive Dendritic Cells Cancer Res., July 1, 2005; 65(13): 5958 - 5964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Kim, L. Cramer, H. Mueller, B. Wilson, and B. J. Vilen Independent Trafficking of Ig-{alpha}/Ig-{beta} and {micro}-Heavy Chain Is Facilitated by Dissociation of the B Cell Antigen Receptor Complex J. Immunol., July 1, 2005; 175(1): 147 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ghadially, X.-L. Ross, C. Kerst, J. Dong, A. B. Reske-Kunz, and R. Ross Differential Regulation of CCL22 Gene Expression in Murine Dendritic Cells and B Cells J. Immunol., May 1, 2005; 174(9): 5620 - 5629. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Garrett, A. V. Emelyanov, M. A. Sepulveda, P. Flanagan, S. Volpi, F. Li, D. Loukinov, L. A. Eckhardt, V. V. Lobanenkov, and B. K. Birshtein Chromatin Architecture near a Potential 3' End of the Igh Locus Involves Modular Regulation of Histone Modifications during B-Cell Development and In Vivo Occupancy at CTCF Sites Mol. Cell. Biol., February 15, 2005; 25(4): 1511 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Palomba, W. K. Roberts, T. Dao, G. Manukian, J. A. Guevara-Patino, J. D. Wolchok, D. A. Scheinberg, and A. N. Houghton CD8+ T-Cell-Dependent Immunity Following Xenogeneic DNA Immunization against CD20 in a Tumor Challenge Model of B-Cell Lymphoma Clin. Cancer Res., January 1, 2005; 11(1): 370 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Spencer, H. J. Kim, A. M. Marques, M. Gonzalez-Juarerro, M. C. B. S. Lima, V. D. Vissa, R. W. Truman, M. L. Gennaro, S.-N. Cho, S. T. Cole, et al. Comparative Analysis of B- and T-Cell Epitopes of Mycobacterium leprae and Mycobacterium tuberculosis Culture Filtrate Protein 10 Infect. Immun., June 1, 2004; 72(6): 3161 - 3170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Young, L. S. Kay, M. J. Phillips, and L. Zhang Antitumor Activity Mediated by Double-Negative T Cells Cancer Res., November 15, 2003; 63(22): 8014 - 8021. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Hostager, S. A. Haxhinasto, S. L. Rowland, and G. A. Bishop Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 Signaling J. Biol. Chem., November 14, 2003; 278(46): 45382 - 45390. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Rubio, Y.-M. Kim, T. Sachs, M. Mapara, G. Zhao, and M. Sykes Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-{gamma} Blood, September 15, 2003; 102(6): 2300 - 2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Macrae, E. J. Usherwood, S. M. Husain, E. Flano, I.-J. Kim, D. L. Woodland, A. A. Nash, M. A. Blackman, J. T. Sample, and J. P. Stewart Murid Herpesvirus 4 Strain 68 M2 Protein Is a B-Cell-Associated Antigen Important for Latency but Not Lymphocytosis J. Virol., September 1, 2003; 77(17): 9700 - 9709. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Briones, J. M. Timmerman, D. L. Panicalli, and R. Levy Antitumor Immunity After Vaccination With B Lymphoma Cells Overexpressing a Triad of Costimulatory Molecules J Natl Cancer Inst, April 2, 2003; 95(7): 548 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sinnathamby and L. C. Eisenlohr Presentation by Recycling MHC Class II Molecules of an Influenza Hemagglutinin-Derived Epitope That Is Revealed in the Early Endosome by Acidification J. Immunol., April 1, 2003; 170(7): 3504 - 3513. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Murphy, L. Welniak, T. Back, J. Hixon, J. Subleski, N. Seki, J. M. Wigginton, S. E. Wilson, B. R. Blazar, A. M. Malyguine, et al. Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses J. Immunol., March 1, 2003; 170(5): 2727 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sigvardsson, D. R. Clark, D. Fitzsimmons, M. Doyle, P. Akerblad, T. Breslin, S. Bilke, R. Li, C. Yeamans, G. Zhang, et al. Early B-Cell Factor, E2A, and Pax-5 Cooperate To Activate the Early B Cell-Specific mb-1 Promoter Mol. Cell. Biol., December 15, 2002; 22(24): 8539 - 8551. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stacey, G.-W. Chang, S. L. Sanos, L. R. Chittenden, L. Stubbs, S. Gordon, and H.-H. Lin EMR4, a Novel Epidermal Growth Factor (EGF)-TM7 Molecule Up-regulated in Activated Mouse Macrophages, Binds to a Putative Cellular Ligand on B Lymphoma Cell Line A20 J. Biol. Chem., August 2, 2002; 277(32): 29283 - 29293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Briones, J. Timmerman, and R. Levy In Vivo Antitumor Effect of CD40L-transduced Tumor Cells as a Vaccine for B-Cell Lymphoma Cancer Res., June 1, 2002; 62(11): 3195 - 3199. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Armstrong, S. Dermime, C. G. Allinson, T. Bhattacharyya, K. Mulryan, K. R. Gonzalez, P. L. Stern, and R. E. Hawkins Immunization with a Recombinant Adenovirus Encoding a Lymphoma Idiotype: Induction of Tumor-Protective Immunity and Identification of an Idiotype-Specific T Cell Epitope J. Immunol., April 15, 2002; 168(8): 3983 - 3991. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Erlach, J. Podlech, A. Rojan, and M. J. Reddehase Tumor Control in a Model of Bone Marrow Transplantation and Acute Liver-Infiltrating B-Cell Lymphoma: an Unpredicted Novel Function of Cytomegalovirus J. Virol., February 22, 2002; 76(6): 2857 - 2870. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Spencer, M. A. M. Marques, M. C. B. S. Lima, A. P. Junqueira-Kipnis, B. C. Gregory, R. W. Truman, and P. J. Brennan Antigenic Specificity of the Mycobacterium leprae Homologue of ESAT-6 Infect. Immun., February 1, 2002; 70(2): 1010 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Biragyn, M. Surenhu, D. Yang, P. A. Ruffini, B. A. Haines, E. Klyushnenkova, J. J. Oppenheim, and L. W. Kwak Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens J. Immunol., December 1, 2001; 167(11): 6644 - 6653. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Weber, C. T. Dao, J. Jun, J. L. Wigal, and P. E. Jensen Transmembrane Domain-Mediated Colocalization of HLA-DM and HLA-DR Is Required for Optimal HLA-DM Catalytic Activity J. Immunol., November 1, 2001; 167(9): 5167 - 5174. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kilmon, R. Ghirlando, M.-P. Strub, R. L. Beavil, H. J. Gould, and D. H. Conrad Regulation of IgE Production Requires Oligomerization of CD23 J. Immunol., September 15, 2001; 167(6): 3139 - 3145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Laurencikiene, V. Deveikaite, and E. Severinson HS1,2 Enhancer Regulation of Germline {epsilon} and {gamma}2b Promoters in Murine B Lymphocytes: Evidence for Specific Promoter-Enhancer Interactions J. Immunol., September 15, 2001; 167(6): 3257 - 3265. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, Y. Torimoto, Y. Tamura, M. Shindo, H. Shinzaki, K. Hirai, and Y. Kohgo Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice Blood, September 15, 2001; 98(6): 1852 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shi and L. A. Eckhardt Deletional analyses reveal an essential role for the hs3b/hs4 IgH 3' enhancer pair in an Ig-secreting but not an earlier-stage B cell line Int. Immunol., August 1, 2001; 13(8): 1003 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cannons, P. Lau, B. Ghumman, M. A. DeBenedette, H. Yagita, K. Okumura, and T. H. Watts 4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy J. Immunol., August 1, 2001; 167(3): 1313 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Shi, S.-R. Park, P.-H. Kim, and J. Stavnezer Roles of Ets proteins, NF-{{kappa}}B and nocodazole in regulating induction of transcription of mouse germline Ig {{alpha}} RNA by transforming growth factor-{beta}1 Int. Immunol., June 1, 2001; 13(6): 733 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Feng, Y. Zeng, L. Whitesell, and E. Katsanis Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity Blood, June 1, 2001; 97(11): 3505 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wallich, A. Siebers, O. Jahraus, C. Brenner, T. Stehle, and M. M. Simon DNA Vaccines Expressing a Fusion Product of Outer Surface Proteins A and C from Borrelia burgdorferi Induce Protective Antibodies Suitable for Prophylaxis but Not for Resolution of Lyme Disease Infect. Immun., April 1, 2001; 69(4): 2130 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iwanami, A. Niwa, Y. Yasutomi, N. Tabata, and M. Miyazawa Role of Natural Killer Cells in Resistance against Friend Retrovirus-Induced Leukemia J. Virol., April 1, 2001; 75(7): 3152 - 3163. [Abstract] [Full Text] |
||||
![]() |
K. M. Haan, A. Aiyar, and R. Longnecker Establishment of Latent Epstein-Barr Virus Infection and Stable Episomal Maintenance in Murine B-Cell Lines J. Virol., March 15, 2001; 75(6): 3016 - 3020. [Abstract] [Full Text] |
||||
![]() |
J. A. Mertz, F. Mustafa, S. Meyers, and J. P. Dudley Type B Leukemogenic Virus Has a T-Cell-Specific Enhancer That Binds AML-1 J. Virol., March 1, 2001; 75(5): 2174 - 2184. [Abstract] [Full Text] |
||||
![]() |
P. Lang, J. C. Stolpa, B. A. Freiberg, F. Crawford, J. Kappler, A. Kupfer, and J. C. Cambier TCR-Induced Transmembrane Signaling by Peptide/MHC Class II Via Associated Ig-alpha /beta Dimers Science, February 23, 2001; 291(5508): 1537 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cannons, Y. Choi, and T. H. Watts Role of TNF Receptor-Associated Factor 2 and p38 Mitogen-Activated Protein Kinase Activation During 4-1BB-Dependent Immune Response J. Immunol., December 1, 2000; 165(11): 6193 - 6204. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boudinot, S. Riffault, S. Salhi, C. Carrat, C. Sedlik, N. Mahmoudi, B. Charley, and A. Benmansour Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways J. Gen. Virol., November 1, 2000; 81(11): 2675 - 2682. [Abstract] [Full Text] |
||||
![]() |
C. M. Mueller and D. W. Scott Distinct Molecular Mechanisms of Fas Resistance in Murine B Lymphoma Cells J. Immunol., August 15, 2000; 165(4): 1854 - 1862. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lapatschek, S. Dürr, R. Löwer, C. Magin, H. Wagner, and T. Miethke Functional Analysis of the env Open Reading Frame in Human Endogenous Retrovirus IDDMK1,222 Encoding Superantigen Activity J. Virol., July 15, 2000; 74(14): 6386 - 6393. [Abstract] [Full Text] |
||||
![]() |
K. Reif and J. G. Cyster RGS Molecule Expression in Murine B Lymphocytes and Ability to Down-Regulate Chemotaxis to Lymphoid Chemokines ,2 J. Immunol., May 1, 2000; 164(9): 4720 - 4729. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shanmugam, M.-J. Shi, L. Yauch, J. Stavnezer, and A. L. Kenter Evidence for Class-specific Factors in Immunoglobulin Isotype Switching J. Exp. Med., April 18, 2000; 191(8): 1365 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Fitzmaurice, L. E. Brown, V. Kronin, and D. C. Jackson The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells Int. Immunol., April 1, 2000; 12(4): 527 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Graner, A. Raymond, D. Romney, L. He, L. Whitesell, and E. Katsanis Immunoprotective Activities of Multiple Chaperone Proteins Isolated from Murine B-Cell Leukemia/Lymphoma Clin. Cancer Res., March 1, 2000; 6(3): 909 - 915. [Abstract] [Full Text] |
||||
![]() |
J. M. Swart, D. M. Bergeron, and T. C. Chiles Identification of a Membrane Ig-Induced p38 Mitogen-Activated Protein Kinase Module That Regulates cAMP Response Element Binding Protein Phosphorylation and Transcriptional Activation in CH31 B Cell Lymphomas J. Immunol., March 1, 2000; 164(5): 2311 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Urashima, H. Suzuki, Y. Yuza, M. Akiyama, N. Ohno, and Y. Eto An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium Blood, February 15, 2000; 95(4): 1258 - 1263. [Abstract] [Full Text] [PDF] |
||||
|
|